NCT06935292View on ClinicalTrials.gov

Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Tracheal Intubation MorbidityLaryngoscopyHemodynamic Response

Interventions

DRUG

Dexmedetomidine

Nebulized Dexmedetomidine (1μg/kg)

DRUG

Melatonin

Oral Melatonin tablet (5mg)

Trial Locations (1)

31527

Tanta University Hospital, Tanta

All Listed Sponsors

lead

Tanta University

OTHER

NCT06935292 - Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients | Biotech Hunter | Biotech Hunter